Free Trial

TransCode Therapeutics (RNAZ) SEC Filings & 10K Form

TransCode Therapeutics logo
$8.07 -1.30 (-13.87%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$7.70 -0.37 (-4.52%)
As of 02/21/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent TransCode Therapeutics SEC Filings

DateFilerForm TypeView
02/14/2025
4:16 PM
Anson Funds Management LP (Filed by)
TransCode Therapeutics (Subject)
Form SCHEDULE 13G
02/04/2025
3:20 PM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:21 PM
TransCode Therapeutics (Filer)
Form DEFA14A
01/03/2025
6:25 PM
SABBY MANAGEMENT, LLC (Filed by)
TransCode Therapeutics (Subject)
Form SCHEDULE 13G
12/30/2024
4:08 PM
TransCode Therapeutics (Filer)
Form DEF 14A
12/19/2024
3:48 PM
TransCode Therapeutics (Filer)
Form PRE 14A
12/17/2024
11:15 PM
TransCode Therapeutics (Filer)
Form EFFECT
12/12/2024
3:15 PM
TransCode Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/06/2024
4:05 PM
TransCode Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/02/2024
3:27 PM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
3:21 PM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
6:54 AM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:34 PM
TransCode Therapeutics (Filer)
Form DEFA14A
11/06/2024
3:05 PM
3i, LP (Filed by)
TransCode Therapeutics (Subject)
Form SC 13G/A
10/28/2024
3:02 PM
TransCode Therapeutics (Filer)
Form DEF 14A
10/15/2024
4:23 PM
TransCode Therapeutics (Filer)
Form PRE 14A
09/27/2024
3:02 PM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
5:02 AM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:04 PM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:45 PM
TransCode Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
8:01 AM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
7:18 AM
TransCode Therapeutics (Filer)
Form 424B5
07/22/2024
3:10 PM
TransCode Therapeutics (Filer)
Form 424B5
06/14/2024
7:00 AM
TransCode Therapeutics (Filer)
Form 8-K/A
06/13/2024
4:06 PM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
7:45 AM
TransCode Therapeutics (Filer)
Form DEFA14A
05/13/2024
4:08 PM
TransCode Therapeutics (Filer)
Form DEFA14A
05/10/2024
3:45 PM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
3:51 PM
TransCode Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RNAZ) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners